Indianapolis, Indiana — According to state and local economic development sources Novartis plans to build out 70,500 square feet of new space in Indianapolis. The company plans to occupy the new space at 8520 Challenger Drive in Indianapolis, on or about June 1, 2022. According to the company website Our purpose is to reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company. Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions – Innovative Medicines and Sandoz – are supported by functional organizations with global scale. Our vision is to become the most valued and trusted medicines company in the world.

To learn more about Novartis, visit http://www.novartis.com/

Company Contact:
Vasant Narasimhan, Chief Executive Officer
https://www.linkedin.com/in/vasnarasimhan/
862-778-8300

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved